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Objective: Lipoprotein lipase (LPL) and hepatic lipase (HL)
are essential in hydrolysis of triglyceride-rich lipoproteins.
LPL activity is negatively, whereas HL activity is posi-
tively, associated with total body fat. We determined the
associations of trunk and leg fat mass with plasma LPL and
HL activities in a cross-sectional study.
Research Methods and Procedures: LPL and HL activities
were determined in post-heparin plasma in a sample of 197
men and 209 women, 60 to 87 years of age. A total body
DXA scan was performed to determine trunk and leg fat
mass.
Results: In women, but not in men, trunk fat mass was
negatively associated with LPL activity, whereas leg fat
mass was positively associated, after mutual adjustment and
adjustment for age. Standardized s (95% confidence inter-
val) for trunk and leg fat mass were 0.24 (0.41; 0.08)
and 0.14 (0.02; 0.31), respectively (interaction by sex,
p  0.03). Larger trunk fat mass was associated with higher
HL activity in men [0.48 (0.28; 0.68)] and women [0.40
(0.24; 0.56)]. A negative association of leg fat mass and HL
activity was observed in men, although not statistically
significant [0.13 (0.33; 0.06)], and in women [0.28
(0.38; 0.18)].
Discussion: Abdominal fat is associated with unfavorable
and femoral fat with favorable LPL and HL activities in
plasma.
Key words: lipase activity, intra-abdominal fat, femoral
fat, DXA
Introduction
It is widely accepted that adiposity, in particular abdom-
inal adiposity, is associated with insulin resistance and
increased risk of type 2 diabetes (1–3).
It has been clearly shown that a preferential visceral
accumulation of fat is independently related to insulin re-
sistance (4). In contrast, larger femoral fat mass measured
by DXA has been found to be associated with more favor-
able concentrations of lipid and glucose concentrations
(5,6). Total body fat is associated with hepatic lipase (HL)1
activity (7) but not with lipoprotein lipase (LPL) activity
(8,9). LPL activity has been shown to be higher in femoral
subcutaneous adipose fat than in visceral fat (10,11). The
femoral region is, therefore, more likely to buffer circulat-
ing free fatty acids (FFAs) by promoting the uptake and the
suppression of the lipolytic release into the circulation (12).
The primary functions of LPL include the clearance of
triglyceride-rich chylomicrons and very-low-density li-
poprotein particles from the bloodstream and the supply of
FFAs to adipose tissue for storage and to skeletal muscle
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tissue for energy production. Whereas LPL is more closely
related to triglyceride degradation for either energy (mus-
cle) or storage (adipose tissue), HL plays a more important
role in remodeling low-density lipoprotein (LDL) and high-
density lipoprotein (HDL) particles by hydrolysis of trig-
lycerides and phospholipids (13). HL activity is sensitive to
sex hormones, with HL activity being lower in women than
in men. Lower LPL activity and higher HL activity have
been described in subjects with type 2 diabetes (14,15).
This study was designed to understand the relationship of
body fat distribution, i.e., abdominal and femoral fat, with
LPL and HL activities. The purpose of the study was to
determine whether the associations of trunk fat and leg fat
as measured by DXA with plasma LPL and HL activities
are different.
Research Methods and Procedures
Design and Population
The Hoorn Study is a population-based cohort study of
glucose metabolism and cardiovascular risk factors among
the inhabitants of the municipality of Hoorn. The study
started in 1989 and consisted of 2484 subjects, as described
before (16). In 2000 to 2001, a follow-up was conducted in
selected subjects 60 to 87 years of age. We invited all
surviving subjects with type 2 diabetes (n  176) and took
random samples of individuals with normal glucose metab-
olism (n  705) or impaired glucose metabolism (n  193)
based on their glucose metabolism status at the previous
examination in 1996 to 1998 (1). Of the 1074 individuals
invited for the 2000 to 2001 follow-up examination, 648
subjects participated (60.3%). Among the reasons for not
participating in the follow-up examinations were lack of
interest (30%), comorbidity (23%), high age (7%), unwill-
ingness to travel (6%), participation considered too time-
consuming (6%), and miscellaneous reasons (15%). Thir-
teen percent were complete non-responders. For this study,
cross-sectional data of this 2000 to 2001 follow-up exami-
nation were examined. A sample of 585 participants was
invited for the post-heparin test, of which 566 participated.
The study was approved by the Ethical Review Committee
of the Vrije Universiteit Medical Center. Informed consent
was obtained from all participants.
Post-heparin Plasma Lipase Activity
LPL and HL activities were measured using an immuno-
chemical method, as described previously (17), in plasma
collected 20 minutes after contralateral intravenous admin-
istration of 50 IU/kg body weight heparin (Leo Pharmaceu-
tical Products, Weesp, The Netherlands). One hundred
seven samples were excluded from the analysis because of
very low activities for LPL and HL in post-heparin plasma.
Activities were considered very low if both LPL activity
was 50 U/liter and HL activity was 72 U/liter. The
post-heparin test was repeated in a sample of subjects with
both low LPL and HL activities (n  10), and normal
activities were measured, indicating that insufficient hepa-
rin delivery was the cause of the low activity.
Genotyping HL Polymorphisms
DNA was extracted from frozen blood. We used the
polymerase chain reaction method as described by Berk-
Planken et al. (14) to assess the presence of the CT
variance in the hepatic lipase gene promoter.
Body Fat and Anthropometry
Body fat was measured by DXA (QDR-2000; Hologic
Europe NV, Belgium). A total body fan beam DXA scan
was performed to determine soft tissue composition at the
standard regions of interest, i.e., trunk and legs. The soft-
ware provided the lean mass, fat mass, and bone mineral
mass for the total body and for the standard regions. In the
analyses, we used fat mass in the trunk and in the legs.
Weight and height were measured in barefoot subjects
wearing light clothes. BMI was calculated by weight di-
vided by height squared. Waist girth was measured at the
level midway between the lowest rib margin and the iliac
crest, and the hip girth was measured at the widest level
over the greater trochanters. Waist to hip ratio was calcu-
lated by waist girth divided by hip girth.
Glycemic Control and Lipids
All participants underwent a 75-gram oral glucose toler-
ance test (OGTT), except those with previously diagnosed
diabetes who were being treated with oral glucose-lowering
medication or insulin. Fasting glucose and 2-hour postload
glucose after OGTT were measured in plasma with the
hexokinase method (Roche Diagnostics, Mannheim, Ger-
many). Hemoglobin A1c was analyzed by high-performance
liquid chromatography (reference range, 4.3% to 6.1%).
Fasting plasma glucose concentration and 2-hour postload
plasma glucose concentration, total cholesterol, HDL-cho-
lesterol, and triglycerides were measured by enzymatic
methods (Roche Diagnostics). LDL-cholesterol was directly
determined by the N-geneous assay (Genzyme, Cambridge,
MA). FFAs were measured in plasma samples by the enzy-
matic colorimetric method (Wako Chemicals, Neuss, Ger-
many). Insulin was determined using a two-site immunora-
diometric test. Paired monoclonal antibodies were used
(Medgenix Diagnostics, Fleurus, Belgium). This test is in-
sulin specific and does not show cross-reactivity with pro-
insulin and split products.
Statistical Analysis
Three glucose metabolism categories were defined ac-
cording to the WHO-99 criteria (18). Participants already
known to have diabetes (n  51) were excluded because
treatment could influence the relationships under consider-
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ation. Two subjects were excluded because of missing DXA
data (logistical reasons). Thus, the study population con-
sisted of 406 individuals: 197 men and 209 women.
Characteristics of the study population are presented by
sex and tertiles of trunk fat. To visualize the associations of
trunk and leg fat with LPL and HL activities, sex-specific
tertiles of trunk fat and leg fat were created, and the popu-
lation of each sex was divided into nine groups by creating
a 3  3 table according to these tertiles. Age-adjusted LPL
and HL activities were calculated in each group and shown
in a figure. To study the independent associations of fat
mass in the trunk and in the legs to the LPL and HL
activities, multiple linear regression analyses were per-
formed. LPL and HL activities were modeled as the depen-
dent variables, and regional fat masses were entered as
independent variables. All regression models were adjusted
for age and lean mass and, subsequently, for triglycerides,
insulin concentration, and FFAs. We tested for interactions
of sex or glucose metabolism by calculating the p values of
the respective interaction terms. All associations of the regres-
sion analyses are reported as standardized . A standardized 
of 0.1 indicates that, if the independent variable increases 1
SD, the dependent variable decreases 0.1 SD. Spearman cor-
relation coefficients were calculated to evaluate relationships
between variables. p values 0.05 (two-tailed) were consid-
ered statistically significant. Statistical analyses were per-
formed with SPSS for Windows version 10.1.
Results
Table 1 shows the characteristics of men and women for
tertiles of trunk fat. Figures 1 and 2 show mean LPL and HL
Table 1. Characteristics (means  SD) of the study population stratified for sex and tertiles of trunk fat
(n  406)
Tertiles of trunk fat
Men Women
I II III I II III
N 65 66 66 69 70 70
Age (years) 68  6 70  6 69  6 69  6 70  6 70  6
NGM, IGM, DM (%) 74/17/9 55/39/6 36/42/21 74/17/9 51/36/13 41/40/19
Fasting glucose (mM) 5.71  0.65 5.80  0.59 6.25  0.98 5.55 0.62 5.81  0.77 6.13  0.95
Postload glucose (mM) 5.92  1.95 6.60  2.33 7.65  2.45 6.29 2.18 7.29  2.16 7.85  2.31
Hemoglobin A1c (%) 5.8  0.5 5.8 0.5 5.9  0.6 5.8  0.4 5.9  0.5 6.0  0.6
Insulin (pM)* 44 (30–58) 49 (37–66) 66 (46–88) 39 (32–51) 51 (39–75) 77 (57–104)
LPL activity (U/liter) 134  46 127  41 135  39 167  51 160  55 149 54
HL activity (U/liter) 370  132 392  130 473  135 312  111 329  124 360 117
CC/CT/TT (%)† 56/40/4 78/20/2 63/33/4 69/29/2 66/30/4 55/41/4
Total cholesterol (mM) 5.2  1.0 5.5  0.9 5.5  1.0 6.2  1.0 6.2  0.9 6.1  0.9
HDL-cholesterol (mM) 1.34 0.43 1.26  0.29 1.23  0.32 1.70 0.42 1.60  0.43 1.53  0.37
LDL-cholesterol (mM) 3.4 0.8 3.6  1.0 3.7  0.9 3.9  0.9 3.8  0.8 3.9  0.9
Triglycerides (mM)* 1.0 (0.9–1.4) 1.3 (1.0–1.9) 1.4 (1.1–2.0) 1.0 (0.8–1.5) 1.3 (0.9–1.8) 1.4 (1.1–1.9)
Lipid-lowering drugs (%) 12 20 17 10 14 14
-blockers (%) 9 8 20 4 20 28
BMI (kg/m2) 24.0  1.8 26.2 1.8 29.7  3.0 23.8  1.8 26.6  2.0 31.3  3.7
Waist-to-hip ratio 0.92  0.05 0.97  0.05 1.02  0.05 0.82 0.06 0.88  0.06 0.90  0.08
DXA total body fat (%) 21.0  3.9 26.8  3.0 33.6  4.7 35.1  4.6 41.3  3.7 47.1  4.2
Trunk fat (kg) 7.14  2.07 11.17  1.01 17.76  4.74 9.02 1.94 13.67 1.50 20.23 3.70
Leg fat (kg) 4.94  1.24 6.13  1.37 8.11  2.14 8.73 2.06 10.15 2.66 12.85 4.07
NGM, normal glucose metabolism; IGM, impaired glucose metabolism; DM, type 2 diabetes; LPL, lipoprotein lipase; HL, hepatic lipase;
HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol.
* For insulin and triglyceride concentrations (skewed data), the median and interquartile ranges are shown.
† HL 480C/T polymorphism.
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activities, adjusted for age, by combined tertiles of trunk fat
and leg fat. In women, but not in men, LPL decreased over
tertiles of trunk fat but increased over tertiles of leg fat. HL
activity increased over tertiles of trunk fat, independently of
leg fat mass, in both men and women. Additional adjust-
ment for lean mass did not change the results (data not
shown). It should be noted that, particularly in men, the
number of subjects in the extreme groups was very small.
The group with low trunk fat and high leg fat consisted of
three men, and the group with high trunk fat and low leg fat
contained only one person.
Using linear regression, neither trunk fat nor leg fat was
significantly associated with LPL activity in men. In con-
trast, in women, trunk fat mass was significantly negatively
associated with LPL activity, whereas leg fat was positively,
although of borderline significance, associated with LPL
activity (Table 2). The differences between men and women
were statistically significant (interaction, p  0.03). After
adjustment for triglyceride or insulin concentrations, the
association of trunk fat and LPL activity in women disap-
peared. For HL activity, in both men and women, trunk fat
was positively associated with HL. In women, and less
strongly in men, leg fat was negatively associated (interac-
tion by sex, p 0.10). These associations were independent
of triglyceride, insulin, and FFA concentrations. The asso-
ciations did not clearly differ among subjects with normal
glucose metabolism, impaired glucose metabolism, or dia-
betes.
Table 3 shows the associations of trunk and leg fat with
LPL and HL activities, stratified for the HL –480 polymor-
phism. In subjects with –480 CT/TT, the association be-
tween fat masses and lipase activities was stronger than in
the –480 CC group in men as well as women, although a
test for interaction did not reach statistical significance.
Discussion
The main finding of this study is that in women, but not
in men, larger trunk fat mass was associated with lower LPL
activity in plasma, whereas larger leg fat mass was associ-
ated with higher LPL activity. Furthermore, trunk fat and
HL activity were positively associated in men and in
women. A negative association between leg fat mass and
HL activity was observed, which was stronger in women
than in men.
Several studies have investigated visceral fat in relation
to LPL and HL activities. Greater abdominal fat and greater
visceral fat have been found to be related to higher HL
activity (19–22). Abdominal and visceral fat have been
negatively associated with LPL activity in most (13,23), but
not all, studies (8,24).
The design of our study cannot address the mechanism by
which trunk fat and leg fat affect LPL and HL activities. It
has been reported that high glucose increases HL mRNA
levels, providing a molecular foundation for a role of hy-
perglycemia in altered lipoprotein metabolism (25). Previ-
ous studies have reported that insulin up-regulates the ac-
tivity of HL through insulin-responsive elements in the HL
promoter, suggesting that variants in this promoter may
affect the ability of insulin to stimulate HL activity (26).
Jansen et al. (27) reported an association between the HL
promoter variants and insulin resistance, suggesting some
potential mechanisms compatible with our results. When
these HL genotypes (CC and CT/TT) were studied sepa-
rately, the association was stronger in the CT/TT group,
although a test for interaction did not reach statistical sig-
nificance (Table 3). This suggests that the HL variant mod-
ulates the effect of fat mass on HL expression. This could be
an important topic for further research because gene–life-
style interactions may help to explain different outcomes of
plasma lipoprotein response in relation to body fat, as well
as conflicting results with regard to lipase activity and
cardiovascular risk.
For LPL, it has been suggested that, compared with
visceral fat, the subcutaneous femoral region is more effec-
tive in storing FFAs and thereby protecting other organs,
Figure 2: Age-adjusted means of plasma HL activity according to
tertiles of leg fat and trunk fat mass. Tertiles of leg fat are now
indicated on the x-axis and tertiles of trunk fat on the z-axis, in
contrast to Figure 1.
Figure 1: Age-adjusted means of plasma LPL activity according to
tertiles of trunk fat and leg fat mass.
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such as the liver, skeletal muscle tissue, and pancreas, from
high FFA exposure, and in this way protects against the
development of insulin resistance and/or ectopic accumula-
tion of triglycerides (10,11,28). Our data support the hy-
pothesis that this protective function is exerted through high
LPL activity in women, because we observed a positive
association between leg fat and LPL activity in women but
not in men. The differences between men and women may
be caused by the difference in the amount of leg fat (6 kg in
men vs. 20 kg in women), suggesting a possible threshold.
A limitation of our study is that plasma LPL activity
consisted of LPL derived from all tissues, and no informa-
tion on tissue-specific activity was available. In addition,
DXA does not allow separate quantification of visceral fat
and subcutaneous fat in the trunk. Therefore, it is not
possible to study site-specific LPL activity or its relation to
fat cell size (29) or the specific contributions of visceral fat
or subcutaneous fat to the observed associations with trunk
fat.
Unfortunately, 20% of the lipase samples had to be
excluded because of insufficient heparin delivery. The ma-
jority of excluded samples were among subjects with im-
Table 2. Associations for trunk and leg fat mass with LPL and HL activities in men (n  197) and women
(n  209)
Standardized  (95% confidence interval)
Men Women
LPL Model 1 Trunk fat (kg) 0.01 (0.21; 0.23) 0.24 (0.41; 0.08)
Model 1  triglycerides 0.12 (0.11; 0.35) 0.15 (0.33; 0.03)
Model 1  insulin 0.05 (0.18; 0.28) 0.09 (0.28; 0.10)
Model 1  FFAs 0.02 (0.24; 0.21) 0.22 (0.39; 0.04)
Model 1 Leg fat (kg) 0.05 (0.27; 0.18) 0.14 (0.02; 0.31)
Model 1  triglycerides 0.11 (0.33; 0.12) 0.06 (0.11; 0.23)
Model 1  insulin 0.04 (0.26; 0.19) 0.10 (0.06; 0.26)
Model 1  FFAs 0.01 (0.22; 0.24) 0.14 (0.02; 0.31)
HL Model 1 Trunk fat (kg) 0.45 (0.25; 0.65) 0.40 (0.24; 0.56)
Model 1  triglycerides 0.43 (0.22; 0.65) 0.30 (0.13; 0.47)
Model 1  insulin 0.43 (0.22; 0.64) 0.33 (0.13; 0.52)
Model 1  FFAs 0.42 (0.21; 0.63) 0.40 (0.23; 0.57)
Model 1 Leg fat (kg) 0.09 (0.29; 0.11) 0.28 (0.38; 0.18)
Model 1  triglycerides 0.08 (0.29; 0.12) 0.19 (0.30; 0.08)
Model 1  insulin 0.08 (0.29; 0.12) 0.26 (0.37; 0.16)
Model 1  FFAs 0.06 (0.27; 0.16) 0.29 (0.39; 0.18)
Model 1 adjusted for age and lean mass.
Table 3. Associations for trunk and leg fat mass with HL activities in men and women stratified for HL
polymorphism and adjusted for age and lean mass (n  393)
Standardized 
(95% confidence interval)
p for interactionCC (n  258) CT/TT (n  135)
Men Trunk fat (kg) 0.40 (0.15; 0.65) 0.52 (0.16; 0.88) 0.73
Leg fat (kg) 0.02 (0.27; 0.23) 0.21 (0.59; 0.18) 0.36
Women Trunk fat (kg) 0.27 (0.06; 0.48) 0.70 (0.43; 0.97) 0.29
Leg fat (kg) 0.16 (0.35; 0.04) 0.54 (0.83; 0.26) 0.44
Trunk and Leg Fat Mass and LPL and HL Activities, Bos et al.
OBESITY RESEARCH Vol. 13 No. 10 October 2005 1821
paired glucose metabolism and type 2 diabetes. However,
there were no noticeable differences between individuals
who were excluded and the rest of the subjects with respect
to lipoproteins, BMI, trunk fat, and leg fat (data not shown).
Furthermore, LPL and HL activities showed the known
associations (30,31) with age, sex, HDL-cholesterol, and
triglyceride concentrations (Table 4). Moreover, after re-
measurement of the post-heparin test in a sample of subjects
with both low LPL and HL activities, normal LPL and HL
activities were measured in these subjects.
Because of the cross-sectional design of this study, it is
not possible to draw conclusions about cause or effect of the
observed associations. Lipases might play a role in fat
distribution, but fat distribution might influence plasma
lipase activities, leading to a more-or-less atherogenic lipid
profile. Thus, prospective studies are needed to determine
the direction of the mechanisms.
In this study we showed in women, but not in men, that
a larger trunk fat mass was associated with lower LPL
activity, whereas a larger fat mass in the legs was positively
associated with higher LPL activity. After adjustment for
triglyceride or insulin concentration, these associations dis-
appeared, possibly suggesting that lipid metabolism and
insulin sensitivity are involved in differential stimulation of
LPL by adipose tissue in different regions or that LPL
activity is involved in the development of insulin resistance.
We observed that larger trunk fat was associated with higher
HL activity in men and women. An opposite association of
leg fat and HL activity was observed in women but the
association was not significant in men. Adjustment for
triglyceride, insulin, and FFA concentrations did not alter
these associations. In conclusion, the fat masses in the trunk
and in the legs have an opposite association with plasma
LPL and HL activities in women. In men, we observed an
opposite association of trunk and leg fat mass with HL, but
there were no associations of trunk or leg fat with LPL
activity. Femoral fat might possibly protect against insulin
resistance through more favorable LPL and HL activities.
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